U.S. imports of rutoside (rutin) and its derivatives (HS 293810) totaled $1.0M in July 2026, traded with 6 countries.
Importers of Rutoside (Rutin) and Its Derivatives paid $15K in duties in July 2026 — an effective duty rate of 2.4% on $630K in dutiable value, based on actual customs collections rather than the published tariff schedule. Rutoside (Rutin) and Its Derivatives imports of $1.0M in July 2026 ran 74% above the year-to-date monthly average of $593K.
Last updated: July 2026 dataRutin is a flavonoid glycoside — quercetin-3-rutinoside — extracted primarily from buckwheat, sophora japonica buds, and other plant sources, and it trades as both a pharmaceutical intermediate and a nutraceutical ingredient used for capillary-fragility indications. China dominates US supply by a wide margin, with Spain and Brazil as secondary sources, reflecting the geographic concentration of buckwheat and sophora cultivation and extraction capacity. Imports intended for pharmaceutical use require FDA admissibility review, while nutraceutical-grade material may enter under dietary supplement regulations with different documentation requirements — making the intended end-use a critical factor in entry planning.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
19 shipments/mo
Pharmaceutical-grade rutin entering as an API must come from an FDA-registered facility and be supported by a Drug Master File or equivalent documentation. Nutraceutical or dietary-supplement-grade rutin is regulated under DSHEA and does not require the same pre-market approval, but the importer of record bears responsibility for ensuring the product meets identity, purity, and labeling standards. Misclassifying pharmaceutical-grade material as a supplement — or vice versa — can result in FDA detention. Consult a licensed customs broker or regulatory counsel for admissibility guidance.
Both natural (plant-extracted) and synthetic rutin and its derivatives classify under heading 2938 as glycosides, with the specific 10-digit line (2938100000) covering the full scope. The extraction or synthesis route does not change the classification, but it may affect FDA regulatory pathway and quality specifications. Importers should confirm the source and processing method in supplier documentation to support both classification and admissibility review.
HSChapter 29
Subheading 2 of 2 in heading 2938
Subheading 293810 · $1.0M of $30.0M
Supplier Network
Get discovered by U.S. importers searching for HS 293810 — Rutoside (Rutin) and Its Derivatives. Be the first supplier listed.
HS10 import codes under this HS6 parent, each with its own page. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Dutiable Share | Duty Collected |
|---|---|---|---|---|---|
| 2938100000 | Rutoside (Rutin) and Its Derivatives) | $1.0M | 1.44% | 60.91% | $15K |
HS10 export codes under this HS6 parent, each with its own page. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 2938100000 | Rutoside (Rutin) and Its Derivatives) | $88K |
Import lines come from the U.S. Harmonized Tariff Schedule and export lines from Schedule B. The two are numbered by different agencies, so the same 10-digit code can appear in both tables describing a different product.
ImportsExports
Imports
$1.0MYoY · Pro
Exports
$88KYoY · Pro
12-mo low · imports
YoY · ProThrough July 2026. Source: U.S. Census Bureau.
Imports · July 2026
origin
China and Spain together supply 100% of it.
customs district
destination
entry
rate provision · imports
39.1% enters free of duty; the effective duty rate is 1.44%.